Lauren Nye, MD

Articles by Lauren Nye, MD

Dr Nye on Paradigm Shifts in the Management of HR+ Breast Cancer

May 16th 2024

Lauren E. Nye, MD, discusses how the expansion of targeted therapies in metastatic hormone receptor–positive breast cancer has shifted management approaches.

Lauren E. Nye, MD, breast medical oncologist, clinical medical director, Breast Cancer Prevention, the University of Kansas Cancer Center

Dr Nye on Future Treatment Directions in HER2+ Breast Cancer Brain Metastases

ByLauren Nye, MD

April 26th 2024

Lauren E. Nye, MD, discusses future directions for the treatment of patients with HER2-positive breast cancer with brain metastases.

Dr. Nye on Neratinib-Associated Diarrhea in HER2+ Breast Cancer

ByLauren Nye, MD

May 21st 2019

Lauren Nye, MD, assistant professor, University of Kansas Medical Center, discusses the concern of neratinib-associated diarrhea in patients with HER2-positive breast cancer.

Latest Updated Articles

Dr. Nye on Neratinib-Associated Diarrhea in HER2+ Breast Cancer
May 21st 2019

Trending on OncLive

FDA Finalizes 3 Guidance Documents to Broaden Cancer Clinical Trial Eligibility Criteria

HR-Positive/HER2-Negative Metastatic Breast Cancer: Treatment Sequencing After Adjuvant Endocrine Therapy and Transitioning Beyond Endocrine-Based Approaches